Akèy › Ipèsansibilite arachid › Arkansas
Etid klinik pou Ipèsansibilite arachid nan Arkansas
6 etid pou Ipèsansibilite arachid ap chèche patisipan nan sit nan Arkansas.
Vil nan Arkansas
Tèks ofisyèl etid la (Anglè)
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
- Arkansas Childrens Hosp Rsch Inst, Little Rock
Ap rekriteFaz 3
Laj 12 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07768371Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology, Little Rock
Ap rekriteFaz 2
Laj 12 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT07015996Study of Oral Food Challenge Biomarkers (SAFER)
- Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology, Little Rock
Ap rekriteEtid obsèvasyon
12 Months – 17 Years · Tout sèks · Mizajou Sep 9, 2026 · NCT07279467Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
- Arkansas Children's Hospital and Research Institute, Little Rock
Ap rekriteFaz 1Volontè an sante akeyi
Laj 12 a 55 · Tout sèks · Mizajou Aug 25, 2026 · NCT07287033Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- Arkansas Children's, Little Rock
Ap rekriteFaz 2
Laj 12 a 55 · Tout sèks · Mizajou Jul 28, 2026 · NCT07220811Safety of MOON101 for the Treatment of Peanut Allergy
- Arkansas Children's Research Institute, Little Rock
Ap rekriteFaz 1
Laj 4 a 55 · Tout sèks · Mizajou Jul 14, 2026 · NCT07580898Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.